EP Patent

EP3018129A1 — Diaryl isoxazoline compound

Assigned to Elanco Tiergesundheit AG · Expires 2016-05-11 · 10y expired

What this patent protects

The present invention concerns the compound of formula or an enantiomer, N-oxide or salt thereof and its use for controlling parasites in and on warm-blooded animals or fish.

USPTO Abstract

The present invention concerns the compound of formula or an enantiomer, N-oxide or salt thereof and its use for controlling parasites in and on warm-blooded animals or fish.

Drugs covered by this patent

Patent Metadata

Patent number
EP3018129A1
Jurisdiction
EP
Classification
—
Expires
2016-05-11
Drug substance claim
No
Drug product claim
No
Assignee
Elanco Tiergesundheit AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.